Clinical pharmacology in renal disease Flashcards

1
Q

Renal disease can cause drugs or their metabolites to accumulate in the body. When is this not particularly hamrful

A

When the drug has a high therapeutic index or low toxicity

When the metabolites have a low toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Outcomes of gentamicin, lithium and digoxin toxicity

A

Gentamicin - Renal or Ototoxicity
Lithium - Renal toxicity, Death
Digoxin - Arrhythmias, Nausea, Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

3 methods of renal excretion

A

Glomerular filtration (main one)
Passive tubular reabsorption
Active tubular secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Where are all drugs and their metabolites filtered

A

The glomerulus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What should be done with a patient with reduced GFR when prescribing drugs

A

REDUCE DOSAGE
Increase dosage interval
Monitor blood levels for toxic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

4 toxic drugs

A

Gentamicin
Vancomycin
Digoxin
Lithium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What effect does renal disease have on the blood brain barrier

A

Makes it more permeable 》brain becomes more sensitive to sedatives, opiates and tranquillisers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What can renal disease do to circulating volume and what caution should be taken

A

Can reduce circulating volume

Making patients very sensitive to antihypertensives (ACE-I or alpha-blockers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What can renal disease do in regards to bleeding and what cautions should be taken

A

Increase bleeding risk

Beware warfarin and NSAID’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How can renal disease alter pharmacokinetics

A

Increased half life
Build up of drug or metabolites
Decreased protein binding 》more free drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How can renal disease alter pharmacodynamics

A

Increased sensitivity to pharmacological action
Increased sensitivity to toxicity
Increased sensitivity to adverse drug reactions ADR’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does TDM stand for

A

Therapeutic drug monitoring (test?)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What should be considered when prescribing a drug to patient with renal impairment

A

Risk/benefit ratio
Severity of toxicity and SE
The availability of TDM
Can a different drug be used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What drugs are ideal for patients with renal impairment

A

Drugs with a High therapeutic index

Drugs that are metabolised by the liver and have non-toxic metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment for hypertension for those with renal impairment

What’s the problem with this treatment

A

ACE-I

Can be nephrotoxic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Four major symptoms of Drug

Induced Renal Disease

A

Acute renal failure
Nephrotic syndrome
Renal tubular dysfunction with potassium wasting
Chronic renal failure

17
Q

3 types of acute renal failure

A

Pre-renal
Renal or Intrinsic
Post-renal or Obstructive

18
Q

What is nephrotic syndrome and give two drugs implicated in it

A

It’s glomerular dysfunction and marked by HEAVY proteinuria

NSAID’S and Interferon

19
Q

Why can NSAID’s cause renal failure

A

Decrease synthesis of renal dilators prostaglandins 》Reducing renal blood flow

20
Q

What happens to urea and creatinine in drug induced renal disease

A

Increase

21
Q

What happens to fluid and electrolytes in drug Induced renal disease

A

Fluid and electrolyte abnormalities

22
Q

When should you really avoid nephrotoxic drugs

A

Patients with renal impairment
Patients that are volume deficient or hypotensive
Patients already receiving nephrotoxic therapy